Invictus MD Strategies Corp Class A IVITF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.02 / $0.03
- Market Cap
- $1,245.83
- Volume/Avg
- 275,950 / 145,200
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 85
- Website
- http://www.invictus-md.com
Valuation
|
Metric
|
IVITF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
IVITF
Financial Strength
|
Metric
|
IVITF
|
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 0.96 |
Interest Coverage | −76.04 |
Quick Ratio
IVITF
Profitability
|
Metric
|
IVITF
|
|---|---|
Return on Assets (Normalized) | −14.47% |
Return on Equity (Normalized) | −18.88% |
Return on Invested Capital (Normalized) | −16.72% |
Return on Assets
IVITF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Vjjmwjlvv | Xlr | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Zhsxrjfdt | Lgvtfqs | $69.1 Bil | |
HLN
| Haleon PLC ADR | Ytrcbdv | Byzy | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Dzgyrhzb | Dbxyh | $15.7 Bil | |
VTRS
| Viatris Inc | Ldgqcmtf | Zkvhn | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Yhvglhxvz | Yqccr | $12.4 Bil | |
CTLT
| Catalent Inc | Cpplkglb | Pwjclm | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jcrwqlpj | Xdq | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Kqlpnyhnv | Tcrs | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bnlhpjfh | Vqxlwz | $3.5 Bil |